Skip to main content
main-content

Type 1 diabetes

Highlights

12-14-2018 | Risk factors | Feature | Article

Sleep duration: Waking up to a major metabolic risk factor

The effect of sleep duration on glucose regulation and cardiometabolic risk is becoming an increasingly high-profile issue. medwireNews takes a look at the latest evidence, which shows the gravity of the problem but also offers some solutions.

10-22-2018 | Mental health | Highlight | News

Insulin manipulation strongly linked to psychiatric comorbidity

Insulin manipulation, the practice of deliberately under- or overdosing insulin, is strongly associated with psychiatric comorbidity in children and young adults with type 1 diabetes, Austrian research shows.

Source:

Pediatr Diabetes 2018; doi:10.1111/pedi.12784

10-04-2018 | Empagliflozin | EASD 2018 | News

EASE: Add-on empagliflozin improves glycemic control in type 1 diabetes

The addition of empagliflozin to insulin therapy reduces glycated hemoglobin levels in patients with type 1 diabetes, indicate findings from the phase III EASE-2 and 3 trials.

Source:

Diabetes Care 2018; doi:10.2337/dc18-1749
EASD Annual Meeting; Berlin, Germany: 1–5 October 2018

09-24-2018 | Diabetic foot ulcers | medwireNews | News

LeucoPatch improves healing of difficult diabetic foot ulcers

Weekly application of an autologous immune cell, fibrin, and platelet patch significantly increases the rate of healing of hard-to-heal foot ulcers compared with standard care in people with diabetes, randomized trial data show.

Source:

Lancet Diabetes Endocrinol 2018; doi:10.1016/ S2213-8587(18)30240-7

09-20-2018 | Pregnancy | Highlight | News

Gluten consumption in pregnancy might influence offspring type 1 diabetes risk

Findings from a large cohort study suggest a dose-dependent relationship between the consumption of gluten in pregnancy and the risk for type 1 diabetes in offspring.

Source:

BMJ 2018; 362: k3547, k3867

09-05-2018 | Blood glucose monitoring | Article

Impact of glucose measuring systems and sample type on diagnosis rates of diabetes mellitus

Blaurock MG et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0495-0

08-31-2018 | Medications | Highlight | News

Poor availability, affordability compromise global diabetes medication use

Diabetes medications are frequently unavailable and unaffordable, particularly in lower-income countries, shows an analysis of the PURE study.

Source:

Lancet Diabetes Endocrinol 2018; doi:10.1016/S2213-8587(18)30233-X

08-26-2018 | Cardiovascular outcomes | Highlight | News

ASCEND results question the use of aspirin, omega-3 supplements in diabetes patients

Findings from a phase IV trial suggest that aspirin use may reduce the risk for primary vascular events but at the cost of increased major bleeding risk in patients with diabetes, while omega-3 fatty acid supplementation does not have a cardioprotective effect.

Source:

N Engl J Med 2018; doi:10.1056/NEJMoa1804988
N Engl J Med 2018; doi:10.1056/NEJMoa1804989

08-22-2018 | Psychosocial care | Editorial | Article

Shared decision-making in patient-centered care

Is the medical model of care failing diabetes patients in its current form? Advisory Board member Katharine Barnard considers this, and the future of clinical decision support.

Author:
Katharine Barnard

08-18-2018 | Continuous glucose monitoring | Review | Article

Prevention and management of severe hypoglycemia and hypoglycemia unawareness: Incorporating sensor technology

Lucidi P et al. Curr Diab Rep 2018; 18: 83. doi: 10.1007/s11892-018-1065-6

08-15-2018 | Neuropathy | Editorial | Article

Are we using the right tests to diagnose diabetic neuropathy?

Uazman Alam and colleagues interrogate current evidence and real-world clinical scenarios to address whether enough is being done with the tools available to screen and diagnose diabetic neuropathy.

Authors:
Shazli Azmi, Andrew Marshall, Andrew Nelson, Uazman Alam

08-10-2018 | Cardiovascular outcomes | Highlight | News

Earlier onset of type 1 diabetes associated with increased risk for adverse outcomes

Patients with type 1 diabetes diagnosed before the age of 10 years have a higher risk for cardiovascular complications and a shorter life expectancy than those who develop the disease at an older age, study results published in The Lancet suggest.

Source:

Lancet 2018; 392: 453–454, 477–486

08-01-2018 | Adolescents | Highlight | News

Motivational interviewing intervention fails to improve HbA1c in adolescents

The Flexible Lifestyles Empowering Change intervention has failed to improve glycated hemoglobin levels in a randomized trial involving adolescents with type 1 diabetes, despite improving some psychosocial outcomes.

Source:

Lancet Child Adolesc Health 2018; doi:10.1016/S2352-4642(18)30208-6


Lancet Child Adolesc Health 2018; doi:10.1016/S2352-4642(18)30241-4

07-24-2018 | Devices and technology | Editorial | Article

The right device at the right time: Optimizing the benefit

Advisory Board member Katharine Barnard scrutinizes the opinion that clinicians should be relying on glycemic outcomes when weighing the decision to prescribe a diabetes device.

Author:
Katharine Barnard

07-16-2018 | Quality of life | Editorial | Article

Tackling clinical inertia: The role of patient engagement

Carmen Soto and David Strain provide their insights on clinical inertia in diabetes care and present the co-production model of open communication as an innovative means to address this widespread clinical issue.

Authors:
Carmen Soto, David Strain MD FCRP

06-24-2018 | Pediatrics | ADA 2018 | News

Parents underestimate type 1 diabetes risk in children

Many parents underestimate their child’s risk for type 1 diabetes, and although accuracy improves following a positive autoantibody result, it subsequently declines with time, a survey of TEDDY participants shows.

06-13-2018 | Ketoacidosis | Highlight | News

Fluid management strategy absolved of neurologic injury blame in childhood DKA

Neither the rate of administration nor the sodium chloride content of replacement fluids given to children with diabetic ketoacidosis influences their neurologic outcomes, show the results of the PECARN DKA FLUID Study.

Source:

N Engl J Med 2018; 378: 2275–2287, 2336–2338

06-07-2018 | Cardiovascular disorders | Highlight | News

20 years’ type 1 diabetes duration marks upshift in CVD risk

Type 1 diabetes duration of at least 20 years is linked to increased cardiovascular disease risk, with an increasing association seen after this time, Australian study results suggest.

Source:

Cardiovasc Diabetol 2018; 17: 77

06-06-2018 | Type 1 diabetes | Case report | Article

Sudden onset of immune-mediated type 1 diabetes mellitus in a 93-year-old woman: A case report

Oriot P et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1170-7

06-01-2018 | Gastrointestinal disorders | Highlight | News

High burden of GI symptoms in patients with type 1 diabetes

People with type 1 diabetes are approximately twice as likely to experience gastrointestinal symptoms as those without, and these symptoms are associated with poor glycemic control and quality of life, study results suggest.

Source:

BMJ Open Diabetes Res Care 2018; 6: e000514

image credits